Lyndra Therapeutics, Inc.

Grantee Website Watertown, Massachusetts, United States
Purpose
to develop a single oral administration with extended release for at least 18 days of both levonorgestrel and ethinyl estradiol which effectively and reliably will provide women in the poorest countries access to voluntary family planning
Division
Global Development
Date
NOVEMBER 2018
Region Served
GLOBAL
Committed Amount
$12,975,269
Grant Topic
Family Planning
Duration (Months)
41
Grantee Location
Watertown, Massachusetts, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.